Akinobu Yoshimura - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Akinobu Yoshimura

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Oncology Reports|January 19, 2008

E-cadherin expression and epidermal growth factor receptor mutation status predict outcome in non-small cell lung cancer patients treated with gefitinibAkihiko Miyanaga, Akihiko Gemma, Masahiro Ando, et al.

BMC Cancer|May 30, 2013

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4-ALK-rearranged non-small-cell lung cancer harbored coexisting EGFR mutationAkihiko Miyanaga, Kumi Shimizu, Rintaro Noro, et al.

Cancers|April 27, 2024

Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from JapanMarin Ishikawa, Kohei Nakamura, Ryutaro Kawano, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Oncology Reports|January 19, 2008

BMC Cancer|May 30, 2013

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4-ALK-rearranged non-small-cell lung cancer harbored coexisting EGFR mutationAkihiko Miyanaga, Kumi Shimizu, Rintaro Noro, et al.

Cancers|April 27, 2024

Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from JapanMarin Ishikawa, Kohei Nakamura, Ryutaro Kawano, et al.

Pageof 6